|
|
|
|
|
Elevated levels of C-terminal agrin fragment and its significance in elderly patients with heart failure complicated with renal injury |
Wang De-guo, Zhao Chun-mei, Wang An-cai, Song Jun |
Department of Geriatrics, Yijishan Hospital of Wannan Medical College, Wuhu 241001, China |
|
|
Abstract Objective To assess the levels of C-terminal agrin-fragment (CAF) and analyze its correlation with renal injury in elderly patients with heart failure. Methods A total of 180 elderly heart failure patients with NYHA class 3-4 who hospitalized into our hospital from December 2013 to December 2014 were enrolled. Based on estimate glomerular filtration rate (eGFR<60 mL·(min·1.73m2), patients with heart failure were divided into renal injury and non-kidney injury groups. Clinical characteristics, laboratory tests, and serum CAF levels were compared between the two groups. Results Among these heart failure patients, 71 cases were complicated with renal injury. Serum CAF level in the renal injury group was significantly higher than that in the non-kidney injury group(ng/L:975±369 vs. 712±350, P=0.028). Correlation analysis showed that heart failure complicated with renal injury was significantly associated with serum CAF level (r=0.249, P=0.001). Even after adjusting for age, gender, serum creatinine, cystatin C and other factors, the increase of serum CAF is still the risk of kidney injury (OR=1.102, 95%CI1.008-1.118, P<0.045). ROC analysis showed that the AUC of CAF>760.7 ng/L for identified kidney injury was 0.690, with the predictive sensitivity of 0.842, and the specificity of 0.423. Conclusion Some patients with heart failure are complicated with renal injury, and the elevated serum CAF levels are correlated with renal function. Abnormally elevated serum CAF has an important clinical significance in identifying renal injury in heart failure patients.
|
|
About author:: Wang De-guo, E-mail:wangdeguo@medmail.com.cn |
|
|
|
[1]Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative[J]. Eur Heart J, 2010, 31(6): 703-711.
[2]Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association[J]. Circulation, 2019, 139(16): e840-e878.
[3]Bonventre JV, Vaidya VS, Schmouder R, et al. Next-generation biomarkers for detecting kidney toxicity[J]. Nat Biotechnol, 2010, 28(5): 436-440.
[4]Stephan A, Mateos JM, Kozlov SV, et al. Neurotrypsin cleaves agrin locally at the synapse[J]. FASEB J, 2008, 22(6): 1861-1873.
[5]Steubl D, Roos M, Hettwer S, et al. Plasma total C-terminal agrin fragment (tCAF) as a marker for kidney function in patients with chronic kidney disease[J]. Clin Chem Lab Med, 2016, 54(9): 1487-1495.
[6]Arampatzis S, Chalikias G, Devetzis V, et al. C-terminal fragment of agrin (CAF) levels predict acute kidney injury after acute myocardial infarction[J]. BMC Nephrol, 2017, 18(1): 202.
[7]Steinbeck L, Ebner N, Valentova M, et al. Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)[J]. Eur J Heart Fail, 2015, 17(12): 1283-1293.
[8]中华医学会心血管病学分会,中华心血管疾病杂志编辑委员会. 慢性心力衰竭诊断治疗指南[J]. 中华心血管病杂志, 2007, 35(12): 1076-1095.
[9]中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管疾病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789.
[10]Daryadel A, Haubitz M, Figueiredo M, et al. The C-Terminal Fragment of Agrin (CAF), a Novel Marker of Renal Function, Is Filtered by the Kidney and Reabsorbed by the Proximal Tubule[J]. PLoS One, 2016, 11(7): e0157905.
[11]Steubl D, Hettwer S, Vrijbloed W, et al. C-terminal agrin fragment-a new fast biomarker for kidney function in renal transplant recipients[J]. Am J Nephrol, 2013, 38(6): 501-508.
[12]Drey M, Behnes M, Kob R, et al. C-terminal agrin fragment (CAF) reflects renal function in patients suffering from severe sepsis or septic shock[J]. Clin Lab, 2015, 61(1-2): 69-76.
[13]游国琼,王丽,段萌. ACLF相关AKI患者的血清集聚蛋白多糖C端片段水平及其诊断价值[J]. 肝脏, 2016, 21(4): 248-252. |
|
|
|